PapersFlow Research Brief
Gastroesophageal reflux and treatments
Research Guide
What is Gastroesophageal reflux and treatments?
Gastroesophageal reflux disease (GERD) is a condition characterized by the reflux of stomach contents into the esophagus causing troublesome symptoms or complications, with treatments including proton pump inhibitors, lifestyle modifications, and management strategies outlined in evidence-based consensuses.
The field encompasses 84,255 papers on the diagnosis, management, epidemiology, and complications of GERD, including esophageal motility disorders, proton pump inhibitors, achalasia, hiatal hernia, laryngopharyngeal reflux, pediatric guidelines, and ambulatory monitoring. Vakil et al. (2006) established the Montreal Definition and Classification of Gastroesophageal Reflux Disease as a global evidence-based consensus to standardize terminology and facilitate research across countries. Lagergren et al. (1999) demonstrated a strong causal relation between symptomatic gastroesophageal reflux and esophageal adenocarcinoma.
Topic Hierarchy
Research Sub-Topics
Gastroesophageal Reflux Disease Epidemiology
This sub-topic studies GERD prevalence, incidence, risk factors, and global burden across populations. Researchers analyze demographic trends, comorbidities, and secular changes using cohort studies.
Proton Pump Inhibitors in GERD Management
This sub-topic evaluates PPI efficacy, optimal dosing, long-term safety, and refractory cases. Researchers conduct RCTs on healing rates, symptom control, and resistance mechanisms.
Esophageal Motility Disorders
This sub-topic covers manometry diagnosis of achalasia, ineffective motility, and GERD associations. Researchers study pathophysiology, high-resolution metrics, and therapeutic outcomes.
Laryngopharyngeal Reflux
This sub-topic investigates extraesophageal reflux manifestations, diagnosis via pH-impedance, and otolaryngology links. Researchers validate symptom indices and response to antireflux therapy.
Ambulatory Monitoring for GERD
This sub-topic develops and validates 24-hour pH, impedance-pH, and Bravo wireless monitoring techniques. Researchers correlate reflux metrics with symptoms and establish diagnostic thresholds.
Why It Matters
GERD management impacts clinical practice by standardizing diagnosis through tools like the Los Angeles classification, which Lundell et al. (1999) validated for assessing oesophagitis and identifying patients at risk of chronic disease. Treatments such as proton pump inhibitors address core mechanisms, while epidemiological insights from Vakil et al. (2006) enable collaborative research and simplified disease handling worldwide. A key example is the finding by Lagergren et al. (1999) of a strong association between reflux symptoms and esophageal adenocarcinoma, highlighting GERD's role in oncologic risk and the need for vigilant monitoring in affected patients.
Reading Guide
Where to Start
'The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus' by Vakil et al. (2006), as it provides the foundational global consensus definition essential for understanding GERD classification and management.
Key Papers Explained
Vakil et al. (2006) in 'The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus' establishes core definitions, which Lundell et al. (1999) build on in 'Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification' by validating endoscopic tools for oesophagitis linked to those definitions. Lagergren et al. (1999) extend this in 'Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma' by quantifying complication risks, informing epidemiological management.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues to emphasize epidemiology, complications, and treatments like proton pump inhibitors for conditions including achalasia and laryngopharyngeal reflux, with focus on pediatric guidelines and ambulatory monitoring.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Montreal Definition and Classification of Gastroesophageal... | 2006 | The American Journal o... | 3.9K | ✕ |
| 2 | Estimation of the global prevalence and burden of obstructive ... | 2019 | The Lancet Respiratory... | 3.7K | ✓ |
| 3 | Association of Sleep-Disordered Breathing, Sleep Apnea, and Hy... | 2000 | JAMA | 3.3K | ✕ |
| 4 | The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Dis... | 2016 | Cardiorenal Medicine | 3.3K | ✓ |
| 5 | Stool Form Scale as a Useful Guide to Intestinal Transit Time | 1997 | Scandinavian Journal o... | 3.1K | ✕ |
| 6 | Symptomatic Gastroesophageal Reflux as a Risk Factor for Esoph... | 1999 | New England Journal of... | 3.0K | ✕ |
| 7 | Functional Gastroduodenal Disorders | 2006 | Gastroenterology | 2.4K | ✕ |
| 8 | Prevalence of sleep-disordered breathing in the general popula... | 2015 | The Lancet Respiratory... | 2.4K | ✓ |
| 9 | Endoscopic assessment of oesophagitis: clinical and functional... | 1999 | Gut | 2.3K | ✓ |
| 10 | Current concepts in the management of Helicobacter pylori infe... | 2006 | Gut | 2.2K | ✓ |
Frequently Asked Questions
What is the Montreal Definition of GERD?
The Montreal Definition classifies GERD as a condition where reflux of stomach contents causes troublesome symptoms or complications. Vakil et al. (2006) developed this global evidence-based consensus in 'The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus' to unify terminology despite regional differences in prevalence and manifestations. It supports standardized management and research collaboration.
How is reflux oesophagitis assessed endoscopically?
The Los Angeles classification provides a reliable system for grading endoscopic oesophagitis. Lundell et al. (1999) validated it in 'Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification', showing strong interobserver agreement. It identifies patients exposed to chronicity risks and correlates with clinical outcomes.
What is the link between GERD and esophageal adenocarcinoma?
Symptomatic gastroesophageal reflux acts as a risk factor for esophageal adenocarcinoma. Lagergren et al. (1999) reported a strong causal relation in 'Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma', based on population data. The association with gastric cardia adenocarcinoma is weaker.
What role do proton pump inhibitors play in GERD treatment?
Proton pump inhibitors form a cornerstone of GERD management by reducing acid production. They are highlighted in the cluster's focus on pharmacological treatments alongside diagnostics like ambulatory monitoring. Consensus reports integrate them into evidence-based strategies.
How does the field address GERD complications?
Complications such as esophageal adenocarcinoma and motility disorders are central to GERD research. Papers cover epidemiology and risks, with Lagergren et al. (1999) quantifying cancer links. Management includes monitoring for hiatal hernia and achalasia.
Open Research Questions
- ? How can regional variations in GERD prevalence and manifestations be better accounted for in global treatment guidelines?
- ? What are the long-term outcomes of proton pump inhibitor use in preventing GERD complications like esophageal adenocarcinoma?
- ? How do interactions between GERD, esophageal motility disorders, and hiatal hernia influence treatment efficacy?
- ? What improvements in ambulatory monitoring can enhance GERD diagnosis accuracy?
Recent Trends
The field maintains 84,255 works with sustained emphasis on GERD diagnosis via consensuses like Vakil et al. and endoscopic validation by Lundell et al. (1999), alongside complication risks from Lagergren et al. (1999); no recent preprints or news indicate steady-state progress in management strategies.
2006Research Gastroesophageal reflux and treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Gastroesophageal reflux and treatments with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers